10.21147/j.issn.1000-9604.2021.05.04
Coexisting opportunities and challenges:In which scenarios can minimal/measurable residual disease play a role in advanced non-small cell lung cancer?
33
This study was supported by Jilin Scientific and Technological Development Program CN No.20190303146SF
2021-12-17(万方平台首次上网日期,不代表论文的发表时间)
共9页
574-582